Life in the crypt: A role for glucagon-like peptide-2?

被引:24
|
作者
Rowland, Katherine J. [1 ]
Brubaker, Patricia L. [1 ,2 ]
机构
[1] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
GLP-2; small intestine; stem cell; crypt; proliferation;
D O I
10.1016/j.mce.2008.02.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The epithelial layer of the intestinal tract serves as a model to study the mechanisms regulating tissue renewal. Central to this process is the intestinal stem cell and, thus, both the intrinsic and extrinsic factors that modulate the function of these cells must be understood. Amongst the intrinsic regulators, both the canonical wnt and bone morphogenic protein (bmp) signaling pathways have been shown to be essential determinants of stem cell dynamics and intestinal homeostasis. The intestinotrophic hormone, glucagon-like peptide-2 (GLP-2), has also recently been demonstrated to exert a variety of effects on the intestinal crypt cells, including enhancement of the putative stem cell marker, musashi-1, as well as stimulating intestinal proliferation. As the GLP-2 receptor is not expressed by the crypt cells, these actions have been hypothesized to be mediated indirectly, through other gut peptides and/or growth factors. Of these, recent studies have demonstrated a requirement for insulin-like growth factor-1 in the proliferative effects of GLP-2, through a pathway that involves activation of the canonical wnt signaling pathway. This extrinsic pathway represents a novel mechanism by which intestinal stem cell dynamics may be regulated. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 50 条
  • [1] Glucagon-like peptide-2
    Estall, Jennifer L.
    Drucker, Daniel J.
    [J]. ANNUAL REVIEW OF NUTRITION, 2006, 26 : 391 - 411
  • [2] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [3] Tales beyond the crypt: Glucagon-like peptide-2 and cytoprotection in the intestinal mucosa
    Estall, JL
    Drucker, DJ
    [J]. ENDOCRINOLOGY, 2005, 146 (01) : 19 - 21
  • [4] Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism
    Lutz, Thomas A.
    Osto, Elena
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2016, 27 (03) : 257 - 263
  • [5] The dimerization of glucagon-like peptide-2 MIMETIBODY™ is linked to leucine-17 in the glucagon-like peptide-2 region
    E. Baker, Audrey
    Sague, Sarah
    Grygiel, Tami L. R.
    Schmidt, Albert
    Rogers, Alison
    Jiang, Haiyan
    Kruszynski, Marian
    Nesspor, Tom
    [J]. JOURNAL OF MOLECULAR RECOGNITION, 2012, 25 (03) : 155 - 164
  • [6] A biological function for glucagon-like peptide-2
    Hussain, MA
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (03) : 265 - 267
  • [7] The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
    de Heer, J.
    Pedersen, J.
    Orskov, C.
    Holst, J. J.
    [J]. DIABETOLOGIA, 2007, 50 (10) : 2135 - 2142
  • [8] The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas
    J. de Heer
    J. Pedersen
    C. Ørskov
    J. J. Holst
    [J]. Diabetologia, 2007, 50 : 2135 - 2142
  • [9] Glucagon-like peptide-2: A potential role in equine insulin dysregulation
    de Laat, M. A.
    Fitzgerald, D. M.
    Sillence, M. N.
    Spence, R. J.
    [J]. EQUINE VETERINARY JOURNAL, 2018, 50 (06) : 842 - 847
  • [10] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
    Nerup, Nikolaj
    Ambrus, Rikard
    Lindhe, Joanna
    Achiam, Michael P.
    Jeppesen, Palle B.
    Svendsen, Lars B.
    [J]. MICROCIRCULATION, 2019, 26 (03)